DE NICOLAO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 9.720
AS - Asia 7.260
EU - Europa 7.073
SA - Sud America 661
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 12
AN - Antartide 1
Totale 24.849
Nazione #
US - Stati Uniti d'America 9.534
CN - Cina 4.391
IE - Irlanda 1.545
SG - Singapore 1.534
UA - Ucraina 1.122
HK - Hong Kong 767
DE - Germania 759
FI - Finlandia 746
RU - Federazione Russa 696
BR - Brasile 541
NL - Olanda 504
SE - Svezia 484
IT - Italia 410
GB - Regno Unito 407
VN - Vietnam 211
FR - Francia 163
CA - Canada 107
IN - India 88
MX - Messico 52
BE - Belgio 49
PL - Polonia 47
AR - Argentina 38
ZA - Sudafrica 35
JP - Giappone 32
BD - Bangladesh 30
IQ - Iraq 26
AT - Austria 25
TR - Turchia 25
EC - Ecuador 24
MA - Marocco 23
ES - Italia 22
PT - Portogallo 21
CO - Colombia 17
VE - Venezuela 15
EU - Europa 14
LT - Lituania 14
ID - Indonesia 13
IR - Iran 13
UZ - Uzbekistan 13
AZ - Azerbaigian 12
JO - Giordania 10
PK - Pakistan 10
SA - Arabia Saudita 10
SK - Slovacchia (Repubblica Slovacca) 10
AU - Australia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
KG - Kirghizistan 8
PY - Paraguay 8
EG - Egitto 7
MY - Malesia 7
CH - Svizzera 6
KE - Kenya 6
PA - Panama 6
DZ - Algeria 5
KR - Corea 5
KZ - Kazakistan 5
LV - Lettonia 5
NO - Norvegia 5
NP - Nepal 5
PE - Perù 5
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
CL - Cile 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
NG - Nigeria 4
OM - Oman 4
UY - Uruguay 4
GA - Gabon 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
JM - Giamaica 3
KW - Kuwait 3
LB - Libano 3
NI - Nicaragua 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
MU - Mauritius 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TO - Tonga 2
TW - Taiwan 2
AD - Andorra 1
AQ - Antartide 1
BF - Burkina Faso 1
Totale 24.827
Città #
Chandler 1.580
Dublin 1.544
Jacksonville 1.338
Nanjing 1.098
Hong Kong 749
Singapore 707
Ashburn 675
Dallas 674
Beijing 610
Boardman 536
Nanchang 423
Princeton 327
Shenyang 306
Lawrence 296
Wilmington 289
Hebei 285
Changsha 265
Jiaxing 255
Los Angeles 245
Ann Arbor 236
Medford 219
Helsinki 160
Tianjin 153
Hangzhou 150
Buffalo 143
Moscow 128
Milan 124
Woodbridge 119
Shanghai 113
Piscataway 105
Munich 95
New York 88
Redondo Beach 88
Dearborn 81
Ho Chi Minh City 70
Verona 65
Norwalk 59
Seattle 53
São Paulo 49
Brussels 47
Chicago 46
The Dalles 45
Pavia 44
Houston 43
Toronto 43
Turku 37
Santa Clara 36
Warsaw 36
Guangzhou 35
Kunming 34
Hanoi 33
Des Moines 32
Falkenstein 32
Zhengzhou 30
Jinan 29
London 27
San Francisco 27
Frankfurt am Main 26
Montreal 26
Tokyo 26
Brooklyn 25
Fairfield 25
Dong Ket 23
Ningbo 23
Stockholm 23
Mexico City 22
Poplar 22
Boston 21
Johannesburg 20
Orem 20
Denver 19
Salvador 18
Washington 18
Atlanta 17
Rome 17
Nuremberg 16
Auburn Hills 15
Chennai 15
Taizhou 15
Changchun 14
Coimbra 14
Manchester 14
Rio de Janeiro 14
Columbus 13
Orange 13
Belo Horizonte 12
Bexley 12
Phoenix 12
Pune 12
Guayaquil 11
Hải Dương 11
Lanzhou 11
Mumbai 11
Somma Lombardo 11
Tashkent 11
Amman 10
Baku 10
Bratislava 10
Calgary 10
Florence 10
Totale 15.854
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 562
A Bayesian approach to non-parametric AUC estimation in population studies 144
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 141
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 140
MPC-based artificial pancreas: Strategies for individualization and meal compensation 133
A stabilizing model-based predictive control for nonlinear systems 129
Artificial pancreas: Model predictive control design from clinical experience 127
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 123
A Bayesian nonparametric approach to AUC determination in population studies 123
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 120
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 120
A Kalman filtering algorithm for regularization networks 120
Continuous-time Markov modelling of flexible-dose depression trials 117
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 115
Multi-step virtual metrology for semiconductor manufacturing: A multilevel and regularization methods-based approach 115
Multistep virtual metrology approaches for semiconductor manufacturing processes 115
A mathematical model to study the effects of drugs administration on tumor growth dynamics 115
A PCA approach to population analysis: with application to a Phase II depression trial 114
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 114
Bayesian population approaches to the analysis of dose escalation studies 111
Modeling myelosuppression in patients treated with anticancer drugs 110
Model predictive control: output feedback and tracking of nonlinear systems 109
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 109
Adaptive Controllers for Intelligent Monitoring 108
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia 108
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 108
Some comments on nu-Support Vector Machines 106
Predicting the active doses in humans from animal studies: A novel approach in oncology 106
An information-theory and Virtual Metrology-based approach to Run-to-Run semiconductor manufacturing control 105
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 105
Tumor growth modelling for drug development 105
A nonparametric approach for model individualization in an artificial pancreas 105
ACID: Automatic classification of sort test maps for interactive process diagnosis 104
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 104
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 104
Process Diagnosis via Electrical-Wafer-Sorting Maps Classification 103
Counting events: population approaches using NONMEM 103
Heart rate correction of the QT interval: a nonparametric individualized approach 103
A mininal model of tumor growth inhibition 103
Particle filtering of hidden Gamma processes for robust Predictive Maintenance in semiconductor manufacturing 103
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 103
Population Pharmacokinetic Model of Ibrutinib, a BTK Inhibitor for the Treatment of B-cell malignancies 103
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 103
A state-space approach to disease and dropout modelling in Phase II clinical trials 102
Multilevel kernel methods for virtual metrology in semiconductor manufacturing 102
A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development 102
A hidden-Gamma model-based filtering and prediction approach for monotonic health factors in manufacturing 102
A new kernel-based approach for system identification 101
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 101
An Algebraic Characterization of the Optimum of Regularized Kernel Methods 101
A New Neural Network Approach for Short-Term Glucose Prediction Using Continuous Glucose Monitoring Time-Series and Meal Information 100
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 100
Multilevel statistical process control of asynchronous multi-stream processes in semiconductor manufacturing 100
Bayesian online multi-task learning of Gaussian processes 99
Kernel methods in system identification, machine learning and function estimation: A survey 99
Identification and idle speed control of internal combustion engines 99
Methods and tools for multiscale modelling in Systems Pharmacology: a review 99
Proportional Hazard Model with L1 Penalization applied to Predictive Maintenance in Semiconductor Manufacturing 98
Second-order indirect response modelling of complex biomarker dynamics 98
AC/ID: a Wafer Oriented Process Diagnosis Techniques 98
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 98
Nonparametric modelling of in vitro antitumor pharmacodynamic studies to optimize drug concentration and treatment time 97
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 97
A new kernel-based approach for linear system identification 97
A collision risk assessment approach as a basis for the on-board warning generation in cars 97
Model Predictive Control of Type 1 diabetes added to conventional therapy 96
A Novel Nonparametric Approach for the Identification of the Glucose-Insulin System in Type 1 Diabetic Patients 96
PK/PD modeling of tumor growth inhibition in vivo 95
H_infinity-robustness of adaptive filters against measurement noise and parameter drift 95
A multi-task learning approach for the extraction of single-trial evoked potentials 95
Output feedback and tracking of nonlinear systems with model predictive control 95
Fast calibration of two-factor models for energy option pricing 95
Population modeling of tumor growth in untreated xenografted mice 94
A new statistical algorithmm to enhance volume diagnostic effectiveness and accuracy 94
Nonparametric input estimation in physiological systems: Problems, methods, case studies 94
Disease and dropout modelling in depression trials: a state-space approach 94
Modeling of human tumor xenografts and dose rationale in oncology 94
Second order Markov modelling of HAMD responses in depression trials 94
A minimal model describing the effect of drug administration on tumor growth dynamics 94
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 94
Nonparametric identification of population models via Gaussian processes 93
A model based approach to the in vitro evaluation of anticancer activity 93
Re: Antitumor Efficacy Testing in Rodents 92
Population modeling of tumor growth inhibition in vivo: application to anticancer drug development 91
Nonparametric identification of pharmacokinetic population models via Gaussian processes 91
Identification of NARX models using regularization networks: A consistency result 91
Population state-space modelling of patient responses in antidepressant studies 91
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 91
Neural spatial pattern recognition of defects in semiconductor manufacturing 90
Unsupervised algorithms for automatic classification of EWS maps: A comparison 90
H-infinity differential Riccati equations: convergence properties and finite escape phenomena 90
On the zeros of discrete-time linear periodic systems 90
Modelling of the outcome of non-inferiority trials by integration of historical data 90
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts 90
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 90
Model predictive control of type 1 diabetes: An in silico trial 89
Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management 89
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 88
Dose escalation studies: a comparison among Bayesian models 88
Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls 88
Totale 10.729
Categoria #
all - tutte 107.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.380 0 0 0 0 0 290 19 291 82 310 289 99
2021/20221.721 20 11 39 20 17 39 22 81 66 29 221 1.156
2022/20234.519 496 310 66 350 543 435 8 238 1.858 31 130 54
2023/20241.537 179 231 75 111 152 328 57 133 13 45 138 75
2024/20253.995 92 401 81 173 131 138 137 373 968 92 436 973
2025/20264.557 700 604 1.031 796 1.146 280 0 0 0 0 0 0
Totale 25.020